DOAK therapy in patients with Antiphospholipid syndrome is not recommendedSeveral pharmaceutical companies indicate that the...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok